🔬DLB Stock: Why Does the Tech Giant Have Strong Fundamentals but Something Holds Back Its Overall Rating?

Dolby Laboratories, an icon in audio and visual technologies, boasts impressive margins and solid fundamental scores. Yet, something seems to be holding back its overall rating, despite the QMA model signaling potential for growth. Data indicate a tension between strong fundamentals and certain factors that are holding the company back in the broader market context.

About the Company

Dolby Laboratories, Inc. (DLB) is a technology company specializing in the development and licensing of audio and video technologies. Its products and solutions are used in a wide range of devices and services, from cinemas and home entertainment systems to mobile phones and streaming platforms. The company operates on a business model of licensing its patented technologies, allowing it to generate stable income from licensing fees. With a market capitalization of $6.34 billion, Dolby falls into the category of mid-sized technology companies in the software applications sector. Its technologies, such as Dolby Digital, Dolby Atmos, and Dolby Vision, are de facto standards in many industries and represent a key component of the multimedia content experience.

Current Developments

Dolby Laboratories' stock has risen by 22% over the past 90 days and by 3.4% over the past 30 days. Currently, it is trading approximately 16% below its 52-week high. The company shows a strong fundamental score (FVS) of 72.5, indicating good value, yet the overall composite score (Composite) is 64.5. This difference signals that while the basic financial health is strong, there are other factors lowering the overall rating. One of these factors is a low earnings quality score (EQS) of 15, which could suggest potential caution regarding the sustainability of future earnings. On the other hand, the catalysts/earnings score (XS) is very high, at 95, which may signal expectations of positive events in the near future.

Why the Company is Interesting — Data Perspective

1. Strong Fundamental Score and High Margins: Dolby Laboratories achieves a fundamental score (FVS) of 72.5, which is an above-average rating pointing to solid financial foundations. This strength is also reflected in high margins: a gross margin of 87.5%, an operating margin of 17.9%, and a net margin of 25.8% for the last reported period. These values indicate effective cost management and a strong market position that allows the company to maintain high profitability from licensing its technologies.

1. Growth Potential According to Model Fair Value: The QMA model at the time of score calculation (September 14, 2026) signals a deviation from the model fair value by 19.8% upwards. This means the model sees room for the stock price to grow above its current level. This potential is also supported by a high catalysts/earnings score (XS) of 95, suggesting that the market may expect positive events that could affect the stock price.

1. Stable Financial Health and Effective Management: The company shows a Piotroski F-Score of 6, which is a solid value indicating good financial health and effective management. The Altman Z-Score, which measures bankruptcy risk, is at 8.74, significantly above the threshold of 3.0, indicating a very low risk of financial distress. The trend in the number of shares is stable, suggesting that the company avoids shareholder dilution through issuing new shares.

Financial Indicators

From the perspective of financial indicators for the last reported period (Q1 2025-12-26), Dolby Laboratories' revenues reached $346.7 million, representing a year-over-year decline of 2.9%. Despite this slight decline, the company maintains high profitability with a gross margin of 87.5%, an operating margin of 17.9%, and a net margin of 25.8%. These margins are typical for a licensing business model, where the cost of goods sold is low. Free cash flow (FCF) was $49.4 million, and operating cash flow was $54.8 million, demonstrating the ability to generate cash from operations. Net income reached $89.5 million. Return on invested capital (ROIC) was 2.4%, and return on equity (ROE) was 3.5%.

Trend Over Periods:
* Q2 2024-03-29: Revenue $364.5 million, net margin 26.8%, FCF $172.5 million.
* Q3 2024-06-28: Revenue $288.8 million, net margin 13.3%, FCF $13.7 million.
* Q4 2024-09-27: Revenue $304.8 million, net margin 19.2%, FCF $108.8 million.
* Q1 2024-12-27: Revenue $357 million, net margin 19%, FCF $100 million.
* Q2 2025-03-28: Revenue $369.6 million, net margin 24.8%, FCF $168 million.
* Q3 2025-06-27: Revenue $315.5 million, net margin 14.6%, FCF $61.3 million.
* Q4 2025-09-26: Revenue $307 million, net margin 16.1%, FCF $101 million.
* Q1 2025-12-26: Revenue $346.7 million, net margin 25.8%, FCF $49.4 million.

The trend shows some seasonality in revenues and FCF, with higher values in Q1 and Q2 and lower in Q3 and Q4. Net margin and FCF exhibit fluctuations, but the company maintains the ability to generate cash, even though FCF slightly declined in the last period.

Valuation in Context

Dolby Laboratories is valued by the market with a P/E ratio of 70.8 and a P/S ratio of 18.28. These multiples are relatively high compared to the broader market and some technology companies, suggesting that the market values the company's future growth potential and strong margins. The FCF yield is 0.8%, which is relatively low and may indicate that the stock is currently valued more on expected future earnings than on current free cash flow. High multiples are often associated with companies with unique technologies and a strong market position, like Dolby. The average target estimate by analysts according to consensus is $90.25, which would correspond to 40% above the price at the time of analysis – these are third-party estimates, not our target or recommendation. The summary rating by third parties is Buy, with a distribution of 8 analysts rating buy, 6 hold, and 3 sell.

Key Risks

1. Dependence on Licensing Fees and Patent Expiry: Dolby Laboratories' business model is heavily dependent on licensing its patented technologies. The risk is the potential expiration of key patents, which could lead to reduced licensing fees and increased competition. Although the company continuously innovates, maintaining a technological edge is crucial for sustaining profitability.

1. Low Earnings Quality (EQS): A low earnings quality score (EQS) of 15 signals potential caution regarding the sustainability and reliability of reported earnings. This may be due to aggressive accounting practices, one-time items, or other factors that make it difficult to assess the company's true operational performance.

1. Competition and Technological Changes: The technology sector is highly competitive and rapidly changing. Dolby faces competition from other technology companies developing audio and video solutions, as well as from in-house solutions of large technology companies. Rapid changes in consumer preferences and technological standards can affect demand for Dolby's licenses.

1. Mixed Insider Activity and Institutional Flow: Over the past 90 days, there have been insider sales worth $2.1 million (5 insiders) against purchases of $1 million (2 insiders). While not massive sales, the predominance of sales may signal that some insiders see the current price as a good opportunity to realize profit. Due to the delay in quarterly reports (published with a delay of ~45 days), there is also a noticeable decline in the number of reported institutions by 109 for the quarter ending June 30, 2026, with the number of closed positions (148) exceeding new ones (41).

This analytical profile is an automated analysis created by QMA Brain – the analytical team of QMA. It is a descriptive and educational analysis based on public data and QMA scores; it is not an investment recommendation or a call to buy or sell. Past performance does not guarantee future results. open stock detail in QMA